Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nirmalya Roy Moulik

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Indian Pediatrics|April 15, 2020
Formulation and Reporting of Guidelines: Providing More Information Will Make Them Better: Authors' ReplyNirmalya Roy Moulik
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|March 7, 2013
The authors reply to Dr. PrashanthM Jayashree, Nirmalya Roy Moulik
Pediatric Blood & Cancer|March 25, 2023
Supportive care in paediatric oncology during the pandemic: Lessons from a nationwide survey in IndiaMaya Prasad, Nirmalya Roy Moulik
Indian Pediatrics|September 18, 2014
Are concerns about folic acid supplementation in children with acute lymphoblastic leukemia justified?Nirmalya Roy Moulik, Archana Kumar
Pediatric Blood & Cancer|February 25, 2017
Long-term risk of portal hypertension and related complications in children treated with 6-thioguanine for acute lymphoblastic leukemia: A single-center experienceNirmalya Roy Moulik, Mary M Taj
Journal of Tropical Pediatrics|March 24, 2015
Successful prevention of varicella outbreak in an overcrowded paediatric oncology ward using oral acyclovir prophylaxisArchana Kumar, Nirmalya Roy Moulik, Nishant Verma
Pediatric Blood & Cancer|June 23, 2022
Comment on: Blinatumomab overcomes poor prognostic impact of measurable residual disease in pediatric high-risk first relapse B-cell precursor acute lymphoblastic leukemiaShyam Srinivasan, Nirmalya Roy Moulik, Chetan Dhamne
The Indian Journal of Medical Research|December 22, 2017
Folic acid, one-carbon metabolism & childhood cancerNirmalya Roy Moulik, Archana Kumar, Suraksha Agrawal
Indian Pediatrics|January 30, 2026
Immunotherapy in Pediatric Oncology in India: A Nationwide Survey Assessing Practices, Perceptions, and Barriers Among Pediatric OncologistsNirmalya Roy Moulik, Chetan Dhamne, Ramandeep Singh Arora
Pediatric Hematology and Oncology|September 21, 2016
Tracking children with acute lymphoblastic leukemia who abandoned therapy: Experience, challenges, parental perspectives, and impact of treatment subsidies and intensified counselingNirmalya Roy Moulik, Ketan Prasad Kulkarni, Archana Kumar
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Indian Pediatrics|April 15, 2020
Formulation and Reporting of Guidelines: Providing More Information Will Make Them Better: Authors' ReplyNirmalya Roy Moulik
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|March 7, 2013
The authors reply to Dr. PrashanthM Jayashree, Nirmalya Roy Moulik
Pediatric Blood & Cancer|March 25, 2023
Supportive care in paediatric oncology during the pandemic: Lessons from a nationwide survey in IndiaMaya Prasad, Nirmalya Roy Moulik
Indian Pediatrics|September 18, 2014
Are concerns about folic acid supplementation in children with acute lymphoblastic leukemia justified?Nirmalya Roy Moulik, Archana Kumar
Pediatric Blood & Cancer|February 25, 2017
Long-term risk of portal hypertension and related complications in children treated with 6-thioguanine for acute lymphoblastic leukemia: A single-center experienceNirmalya Roy Moulik, Mary M Taj
Journal of Tropical Pediatrics|March 24, 2015
Successful prevention of varicella outbreak in an overcrowded paediatric oncology ward using oral acyclovir prophylaxisArchana Kumar, Nirmalya Roy Moulik, Nishant Verma
Pediatric Blood & Cancer|June 23, 2022
Comment on: Blinatumomab overcomes poor prognostic impact of measurable residual disease in pediatric high-risk first relapse B-cell precursor acute lymphoblastic leukemiaShyam Srinivasan, Nirmalya Roy Moulik, Chetan Dhamne
The Indian Journal of Medical Research|December 22, 2017
Folic acid, one-carbon metabolism & childhood cancerNirmalya Roy Moulik, Archana Kumar, Suraksha Agrawal
Indian Pediatrics|January 30, 2026
Immunotherapy in Pediatric Oncology in India: A Nationwide Survey Assessing Practices, Perceptions, and Barriers Among Pediatric OncologistsNirmalya Roy Moulik, Chetan Dhamne, Ramandeep Singh Arora
Pediatric Hematology and Oncology|September 21, 2016
Tracking children with acute lymphoblastic leukemia who abandoned therapy: Experience, challenges, parental perspectives, and impact of treatment subsidies and intensified counselingNirmalya Roy Moulik, Ketan Prasad Kulkarni, Archana Kumar
Pageof 7